Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14 ++ CD16 + intermediate monocytes from a pro‐inflammatory to an anti‐inflammatory phenotype

Authors

Emily L. Williams, University of Bristol
Madeleine L. Stimpson, University of Bristol
Philippa J.P. Lait, University of Bristol
LP Schewitz‐Bowers
Lauren V. Jones, University of Bristol
Ashwin D. Dhanda, Peninsula Medical School
Richard W.J. Lee, University College London
Charlotte A. Bradbury, University Hospitals Bristol and Weston NHS Foundation Trust

ORCID

• Ashwin D. Dhanda: 0000-0002-0523-0193

DOI Link

10.1111/bjh.17205

DOI

10.1111/bjh.17205

Publication Date

2021-01-18

Publication Title

British Journal of Haematology

Volume

192

Issue

2

ISSN

0007-1048

Embargo Period

2021-08-14

First Page

375

Last Page

384

Recommended Citation

Williams, E., Stimpson, M., Lait, P., Schewitz‐Bowers, L., Jones, L., Dhanda, A., Lee, R., & Bradbury, C. (2021) 'Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14 ++ CD16 + intermediate monocytes from a pro‐inflammatory to an anti‐inflammatory phenotype', British Journal of Haematology, 192(2), pp. 375-384. Available at: 10.1111/bjh.17205